Skip to main content
. 2011 Jun 23;38(10):1854–1861. doi: 10.1007/s00259-011-1862-5

Table 1.

Patient characteristics

Number of evaluable patients 76
Sex (n: male/female) 42/34
Age median (range) 58 (17–79)
New patients vs patients with known disease (n) 30/46
Metastatic disease (n) 74
Location of primary tumour
 Bronchus (n) 5
 Duodenum (n) 4
 Small intestine: jejunum-ileum (n) 62
 Colon (n) 5
Treatment
 Somatostatin analogue treatment (n) 28
 Interferon treatment (n) 2